The antiphospholipid syndrome: Immunologic and clinical aspects. Clinical spectrum and treatment

Journal of Rheumatology

Volumn 27, Issue SUPPL. 58, 2000, Pages 20-28

  Myones, Barry L ^a,c   McCurdy, Deborah ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Antiphospholipid antibody; Clinical Review; Park City; Pediatric; Thrombosis; Treatment

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; HUMAN; PATHOGENESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TREATMENT INDICATION; VEIN THROMBOSIS;

AGE OF ONSET; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; THROMBOSIS;

EID: 0034115413     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322-6.
2. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989;73:541-5.
3. Brey RL, Gharavi AE, Lockshin MD. Neurologic complications of antiphospholipid antibodies. Rheum Dis Clin North Am 1993; 19:833-50.
4. Fessier BJ. Thrombotic syndromes and autoimmune diseases. Rheum Dis Clin North Am 1997;23:461-79.
5. Harris EN. Clinical implications of the antiphospholipid syndrome. Intern Med 1994;15:56-69.